Those Hard Lumps Aren’t Just “Gout Bumps”, and There Are Trials That May Help

New meds for gout tophi: Clinical trials now open

Those hard gout bumps may be tophi, and new meds for gout are being studied right now. Learn about clinical trials recruiting for gout today.

If you’ve been living with gout for a while, there’s a good chance you’ve noticed something beyond the flares: hard lumps near your toes, knuckles, elbows, or ankles. Maybe they’re pea sized. Maybe they’ve grown to something bigger. Maybe they’ve cracked the skin and leaked something chalky and white.

You might have even Googled them, possibly shown them to a doctor, or asked about them in our gout community, but also possibly never gotten a really clear answer about what they actually are, or what you can do about them.

So here’s what we think you should know about the bumps or lumps, they actually have a name, and there are researchers actively working on treatments right now, including clinical trials that are currently looking for people like you.

So, what are these lumps, actually?

In the gout world, those hard knots and bumps are called tophi (one is a tophus). You’ll also see the term “tophaceous gout” used, which basically means gout that has progressed to the point where uric acid crystals have physically built up under your skin and around your joints.

We hear patients describe them all kinds of ways in our community:

• “Rock hard lump on my big toe knuckle”
• “Chalky white stuff oozing out of a bump on my ankle”
• “Something that looks like a cyst behind my knee”
• “Bumps on my fingers that won’t go away”
• “Feels like there’s broken glass in my joint”
• “My elbow has this huge knot and I can’t even lean on it”

That’s all tophaceous gout. Different shapes, different sizes, different locations, but in the end, the same underlying cause. Uric acid that has been high for too long, building up in places it shouldn’t be.

LIttle important note for ya, tophi don’t form overnight. They’re a sign of long standing uncontrolled gout. Which means possibly years of high uric acid that may have been under treated or even completely untreated. No judgement, stigma around gout is our whole mission! Most of us weren’t even told this was happening until it had already been building for a while. But we’re out here trying to change that.

If any of that sounds familiar, the lumps, the frustration, the years of thinking this was just how gout goes, you’re not alone. And you’re exactly who this post is for.

If you recognized yourself somewhere in that list, the hard knots, the chalky bumps, the joint that won’t bend right, the years of just managing and moving on, that isn’t just “bad gout.” That’s a specific, treatable stage of this disease. And right now, there are researchers actively studying new ways to treat it. Which means there may be options you haven’t had before.

A gout clinical trial might be something to consider …

We want to be upfront about who these clinical trials are looking for, in plain terms. You might be a good fit if:

• You have one or more hard, visible lumps near your joints (even if they’re not currently painful)
• You’ve had gout for several years and feel like your treatment has never fully gotten things under control
• Your uric acid levels have stayed high even while taking medication
• You’ve tried allopurinol or febuxostat and it hasn’t resolved your tophi
• You’ve had infusion treatments for gout (like pegloticase) but they stopped working
• You’re frustrated that your tophi are still there and want to explore more options

You might not be a fit if your gout is well controlled, your uric acid is at target, and you’re not dealing with visible tophi. That’s okay though, these trials are specifically for people in that ‘harder to treat’ group.

Each trial has its own eligibility criteria, and the research team will walk you through it before anything is confirmed. There’s no pressure if you wanna have a conversation, just information.

Before you read on: A few things we always like to note

If you’re new to the idea of clinical trials, here’s the honest version:

• Most gout clinical trials are no cost to you. Medications, labs, and visits are typically covered by the sponsor
• You can leave a trial at any time. Participation is always voluntary
• You’ll be monitored closely by a medical team throughout
• Trials involve some uncertainty, you may receive a treatment still being studied, and side effects are possible
• Not everyone qualifies, eligibility is based on your specific health profile

Trials aren’t right for everyone. But for many people in our gout community, especially those who feel stuck or are dealing with tophi that haven’t responded to standard treatments, new meds for gout via clinical trials can be a real path forward.

You can also visit our Gout Clinical Trials page for a full ‘plain language’ overview of how trials work, what to expect, real stories from people who’ve participated, and we even break down the most frequently asked questions around gout clinical trials.

Currently recruiting: three trials for tophaceous gout

Below are three clinical trials currently enrolling participants for gout, that we thought might be helpful for those in our gout community who want more options for treating their gout bumps and lumps.

---

Trial 1: A New Daily Pill vs. Allopurinol | Dotinurad Study

Trial ID: NCT07089888 | Phase III

This trial is comparing a new once daily oral medication called dotinurad against allopurinol (the most commonly prescribed gout medication), in people who have tophaceous gout.

Dotinurad works by helping your kidneys excrete excess uric acid through your urine. It’s already approved for gout treatment in Japan, China, and other parts of Asia, and this study is evaluating it for use in the United States.

What the study involves:

• About 250 participants will be enrolled
• You’ll be randomly assigned to receive either dotinurad or allopurinol, neither you nor the research team will know which one you’re taking (this is called a double-blind study)
• The treatment phase runs for 76 weeks (about a year and a half)
• Researchers will track uric acid levels, whether tophi shrink or resolve, and flare frequency
• If you complete the main trial, you’ll have the option to continue in a long term extension where everyone receives dotinurad

What they’re trying to find out:

Which treatment does a better job of lowering uric acid, reducing tophi, and preventing flares over the long haul. This kind of head to head comparison gives researchers and future patients real data on whether a new option outperforms the current standard.

Learn more about the JEWEL Program, which may potentially help reduce uric acid levels in the blood and improve your gout symptoms.

Their Ruby Study is for patients diagnosed with gout, and their Topaz Study is for patients diagnosed with tophaceous gout

Learn more from the clinical trial team here: https://en-us.jewelprogram.com/

Learn more on the Clinical Trials Gov website: NCT07089888 on ClinicalTrials.gov

---

Trial 2: A Combination Approach for People Who Haven’t Found Relief | AR882 + XOI Study

Trial ID: NCT07116746 | Phase II

This trial is for people with tophaceous gout whose previous uricase-based treatment hasn’t worked, whether because of a reaction, intolerance, or the treatment losing effectiveness over time. If that’s you, this study was designed with people like you in mind.

What the study involves:

• The medication being studied is called pozdeutinurad (AR882), it’s an oral medication that helps your body excrete excess uric acid through the urine
• It’s being used in combination with a standard gout medication called a xanthine oxidase inhibitor (XOI)
• There is no placebo in this study, all participants receive the combination treatment
• Researchers will monitor how well it lowers uric acid levels, reduces tophi (those hard gout lumps we’re learning about), and whether it is safe and well tolerated

What they’re trying to find out:

Whether this oral combination can effectively lower uric acid, shrink tophi, and offer a safe path forward for people who have struggled with, or couldn’t continue uricase-based treatment. The fact that everyone in the study receives the active treatment (no placebo) means every participant is getting the real thing.

Learn more about this trial here: With Power – Clinical Trials

Learn more on the Clinical Trials Gov website: NCT07116746 on ClinicalTrials.gov

---

Trial 3: Could a Simple Shot Replace the IV Drip? | Pegloticase Subcutaneous Study

Trial ID: NCT07388498 | Phase III

If you’ve heard of pegloticase (brand name Krystexxa), the infusion treatment for ‘hard to control’ gout, you probably know that getting it means a trip to a clinic every two weeks for an IV drip. That’s a real barrier for a lot of people. Time off work, travel, sitting in an infusion chair, etc. Trust, I’ve done it.

This trial is asking a question that matters a lot for patients: what if you could get the same medication as a simple injection under the skin instead, the same way you’d take a flu shot?

What the study involves:

• Participants are randomly assigned to receive pegloticase either as a subcutaneous injection (a shot under the skin) or as the standard IV infusion, every two weeks
• Both groups also take methotrexate, which helps reduces the risk of reactions
• The study is double-blind. Neither participants nor the research team know which method is being used, keeping the comparison fair
• Researchers will track how well each method lowers uric acid levels, controls gout symptoms, and how safe each route is

What they’re trying to find out:

Whether the subcutaneous shot can match the IV infusion in results and safety. If it can, that would be a meaningful step forward for patients, potentially making this gout treatment easier and more accessible to get.

This trial is for people with uncontrolled gout who haven’t had success with standard oral medications. It’s run by Amgen, the maker of pegloticase.

Learn more about this trial here: With Power – Clinical Trials

Learn more on the Clinical Trials Gov website: NCT07388498 on ClinicalTrials.gov

---

You don’t have to just live with this

Those lumps. The ones that make shoes hurt. The ones you hide at the beach. The ones that have been there for years while you hoped they’d shrink on their own.

Tophaceous gout is the part of this disease that most patients were never told about until it was already visible. For generations, people were handed a script about gout, that it was about diet, that flares were just part of life, that not much else could be done.

But that story is changing. Research is moving. And trials like these exist because there are real scientists who believe you deserve better options.

If you think any of these studies might be for you, take a look. Ask questions. Lots of questions, all the questions you can think of. Talk it over with your doctor. You are allowed to want more than you’ve been given.

And as always, you’re not doing this alone. Our community is here.

Questions about clinical trials? Visit our Gout Clinical Trials page or ask in the community.

Post sponsored by Crystalys Therapeutics